TBIO - Codex DNA Net Sales Margin

TBIO (Codex DNA) - company brandmark

Telesis Bio, Inc. (TBIO) is aggressively capturing the B2B DNA synthesis segment, leveraging its status as a defensive asset independent of macroeconomic trends. In the net sales margin spread on the GURU.Markets platform, this chart illustrates where -295.90 determines this parameter level. BioXp robots drive efficiency gains by automating routine biomaterial assembly, freeing scientists for strategic tasks.

Telesis Bio, Inc (TBIO) Net Return on Sales: for the period 04/28/2023 - 10/05/2024

Summary analytical data breakdowns for Telesis Bio, Inc. (TBIO)

- share price and consensus valuation forecast:
Fundamental company valuation:Telesis Bio - TBIO
Finished products of Telesis Bio, Inc

Net profitability determines business resilience to market shocks through the share of profit in every dollar of revenue. Recruiting highly qualified bioengineers creates a technological barrier that supports the high added value of Telesis Bio products. This metric measures cost management efficiency in real-time. By analyzing the integral net margin indicator, an investor sees the current margin of safety, which allows for the distinction between a temporary drawdown and a systemic crisis.

Direct competitors

TEM: Net Sales Margin|Net Profitability Margin Qiagen QGEN|IONS (Isis Pharmaceuticals) - Net Sales Margin|Repligen Inc. - Net Profit Margin|Net Sales Margin RNA|CRSP - Net Margin|GeneDx - Return on Sales by Net Profit|Net Profit Rate RARE|Beam Tx - Net Sales Margin|SRPT - Net Sales Margin|TWST (Twist Bio) - Return on Sales by Net Profit|Net Return on Sales TXG|Return on Sales by Net Profit NTLA|Stoke Therapeutics Inc (STOK) - Company Sales Margin|Net Sales Margin BLFS|Net Margin WVE (Wave Life Sciences Corp)|Net Margin Maze Therapeutics MAZE|Net Profit Rate SION|PRME - Net Margin|Company Sales Margin Taysha TSHA|QURE: Net Sales Margin|Return on Sales by Net Profit MeiraGTx PLC|RGNX (REGENXBIO Inc) - Net Sales Margin|solidbio.com (SLDB) - Company Sales Margin|Net Margin Ocugen Corp (OCGN)|Pacific Biosciences of California, Inc. - Net Return on Sales|Benitec Biopharma - Return on Sales by Net Profit|DSGN: Net Return on Sales|RCKT: Return on Sales by Net Profit|FDMT - Net Sales Margin|LXEO: Net Sales Margin|Korro Bio Inc. - Net Profit Rate|EDIT (editasmedicine.com) - Net Sales Margin|Net Margin SLN|Net Margin ProQR Therapeutics NV (PRQR)|Codexis - Net Return on Sales|Net Margin Sangamo SGMO|NAUT: Net Return on Sales|MGX: Return on Sales by Net Profit|Net Margin Precision BioSciences|GBIO (generationbio.com) - Return on Sales by Net Profit|Net Margin boundlessbio.com (BOLD)|XCUR (exicuretx.com) - Net Sales Margin|Net Return on Sales IMNN (Imunon, Inc.)|Net Sales Margin PHIO|MBIO - Net Margin|Net Sales Margin RNAZ (TransCode Therapeutics)|bionanogenomics.com (BNGO) - Net Margin|Applied DNA - Net Sales Margin|Net Margin Bluebird Bio|ImmunoPrecise (IPA) - Net Margin|Net Profit Margin OMGA (Omega)|Net Margin Singular Genomics Systems|Net Margin regulusrx.com RGLS|Net Margin Syros Pharmaceuticals Inc. (SYRS)|Net Sales Margin TRACON Pharmaceuticals Inc. (TCON)|Net Margin Unity Bio UBX